Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study

Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study

Background: Acquired brain injury can cause disorders of consciousness. An additive effect of cerebrolysin and amantadine has been postulated, but not systematically studied. The present study aimed to investigate this additive effect in patients with disorders of consciousness secondary to acquired...

Full description

Bibliographic Details
Main Authors:	Seunghwan Lee, Hyun Haeng Lee, Yejin Lee, Jongmin Lee
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2020-02-01
Series:	Journal of Rehabilitation Medicine
Subjects:	cerebrolysin amantadine disorders of consciousness acquired brain injury responsiveness
Online Access:	https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2654

Similar Items

Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study
by: Jun Yup Kim, et al.
Published: (2019-08-01)

The Effectiveness of Amantadine in Improving Consciousness in Patients with Acute Brain Injury
by: Alireza Rahat Dahmardeh, et al.
Published: (2023-08-01)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
by: Stefan Strilciuc, et al.
Published: (2023-05-01)

The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
by: Konrad Jarosz, et al.
Published: (2024-01-01)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
by: Konrad Jarosz, et al.
Published: (2023-03-01)

"Efficacy of interferon and Amantadin for treatment of hepatitis in major thalasemia at Children’s Medical Center, Tehran "
by: Fallahi GHI, et al.
Published: (2007-04-01)

Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure
by: Dong Hyeon Kang, et al.
Published: (2020-10-01)

A Case Report of Severe Delirium after Amantadine Withdrawal
by: Franz Marxreiter, et al.
Published: (2017-03-01)

Cerebrolysin Use in Patients with Liver Damage—A Translational Study
by: Shandiz Morega, et al.
Published: (2022-11-01)

Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
by: Nataliia Chemer, et al.
Published: (2019-02-01)

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
by: Klaudyna Kojder, et al.
Published: (2023-10-01)

Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation
by: Gustavo Villarreal-Reyna, et al.
Published: (2022-11-01)

Effect of cerebrolysin on motor function restoration during medical rehabilitation
by: M. A. Kustova, et al.
Published: (2016-07-01)

Amantadine for NeuroenhaNcement in acutE patients Study - a protocol for a prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)
by: Anna Hofmann, et al.
Published: (2023-08-01)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
by: Dafin F. Mureșanu, et al.
Published: (2022-02-01)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
by: Sharma VD, et al.
Published: (2018-04-01)

Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials
by: Stefan Strilciuc, et al.
Published: (2021-12-01)

Myoclonus Secondary to Amantadine: Case Report and Literature Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-07-01)

Amantadine-induced livedo reticularis - Case report
by: Maria Victória Quaresma, et al.
Published: (2015-10-01)

Right ventricular outflow tract tachycardia after an initial dose of amantadine
by: Cüneyt Kocaş, et al.
Published: (2015-07-01)

Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid
by: Calderón Guzmán David, et al.
Published: (2016-09-01)

Evaluation of the combined therapeutic effect of methylprednisolone and cerebrolysin in traumatic medullar lesion
by: Adriana Baritchii, et al.
Published: (2011-12-01)

Amantadine Induced Corneal Edema in a Patient with Primary Progressive Freezing of Gait
by: Young Eun Kim, et al.
Published: (2013-10-01)

Amantadine as Augmentation in Managing Opioid Withdrawal with Clonidine: a randomized controlled trial.
by: Shahrokh Amiri, et al.
Published: (2014-09-01)

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
by: Aryun Kim, et al.
Published: (2018-05-01)

AMANTADINES: EXPERIENCE OF APPLICATION FOR PARKINSON DISEASE
by: A. A. PILIPOVICH, et al.
Published: (2016-12-01)

Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study
by: Daniel Chober, et al.
Published: (2022-11-01)

Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study
by: Dina R. Khasanova, et al.
Published: (2023-03-01)

Variations of Aripiprazole-Induced Dyskinesia Existing with Concurrent Use of Amantadine and an Anticholinergic Agent in an Elderly Patient
by: I-Wen Sun, et al.
Published: (2012-06-01)

Protective effects of cerebrolysin in a rat model of optic nerve crush
by: Tzu-Lun Huang, et al.
Published: (2014-07-01)

Amantadine toxic effect and acute psychosis – a case report
by: Dariusz Gruca, et al.
Published: (2023-01-01)

Cerebrolysin Combined with Rehabilitation Enhances Motor Recovery and Prevents Neural Network Degeneration in Ischemic Stroke Patients with Severe Motor Deficits
by: Won Hyuk Chang, et al.
Published: (2021-06-01)

Cerebrolysin recovers diaphragmatic function and reduces injury-associated astrogliosis following a cervical spinal cord hemi-section injury in rats
by: Samah Fouad, et al.
Published: (2023-08-01)

Experience of Using Amantadine Sulfate (PK-Merz) in Patients with Ischemic Stroke
by: Viktoria Anatoliivna Gryb, et al.
Published: (2016-09-01)

Amantadine in the treatment of Pathological Gambling: a case report
by: Mauro ePettorruso, et al.
Published: (2012-11-01)

Amantadine, new look at the well-known medicine
by: Andrzej Stańczak, et al.
Published: (2022-11-01)

Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease
by: N. V. Titova, et al.
Published: (2021-03-01)

Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial
by: Mikhail N. Kalinin, et al.
Published: (2024-01-01)

In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides
by: Jorge L. Arias-Arias, et al.
Published: (2021-09-01)

The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice
by: Nuha Milad Ashtiwi, et al.
Published: (2022-05-01)